Advanced

The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data

Bengtsson, Boel LU ; Heijl, Anders LU ; Johannesson, Gauti; Andersson-Geimer, Sabina LU ; Aspberg, Johan LU and Lindén, Christina (2018) In Acta Ophthalmologica 96((6)). p.557-566
Abstract
Crown Princess Margareta's Foundation, the Herman Järnhardt Foundation, the Foundation for Visually Impaired in Former Malmöhus County, Ögonfonden, Ingrid Nordmark's Foundation, the Margit and Kjell Stolz Foundation, foundations and donations administered by Skåne University Hospital, and King Gustav V and Queen Victoria's Freemason Foundation, Swedish Society for Medical Research, Swedish Medical Society Foundation and Cronqvist Foundation. Financial support was also provided through a regional agreement between Lund University and Skåne County Council (ALF) and by Umeå University and Västerbotten County Council (ALF).The sponsors and funding organizations had no role in the design or performance of this... (More)
Crown Princess Margareta's Foundation, the Herman Järnhardt Foundation, the Foundation for Visually Impaired in Former Malmöhus County, Ögonfonden, Ingrid Nordmark's Foundation, the Margit and Kjell Stolz Foundation, foundations and donations administered by Skåne University Hospital, and King Gustav V and Queen Victoria's Freemason Foundation, Swedish Society for Medical Research, Swedish Medical Society Foundation and Cronqvist Foundation. Financial support was also provided through a regional agreement between Lund University and Skåne County Council (ALF) and by Umeå University and Västerbotten County Council (ALF).The sponsors and funding organizations had no role in the design or performance of this research.Acknowledgement/disclosures: The design of the GITS was briefly presented at the Nordic Glaucoma Congress in September 2017.The trial is supported by grants from Crown Princess Margareta's Foundation, the Herman Järnhardt Foundation, the Foundation for Visually Impaired in Former Malmöhus County, the Swedish Eye Foundation, Ingrid Nordmark's Foundation, the Margit and Kjell Stolz Foundation, foundations and donations administered by Skåne University Hospital, and King Gustav V and Queen Victoria's Freemason Foundation, Swedish Society for Medical Research, the Swedish Medical Society Foundation, and the Cronqvist Foundation. Financial support was also provided through a regional agreement between Lund University and Skåne County Council (ALF), and by Umeå University and Västerbotten County Council (ALF). The sponsors and funding organizations had no role in the design or performance of this research.Financial disclosures: Dr Bengtsson is a consultant to Carl Zeiss Meditec. Dr Heijl is a consultant to Carl Zeiss Meditec and Allergan, and has received speaking honoraria from Allergan, Zeiss and Santen. Dr Johannesson reports speaking honoraria and/or consulting for Topcon, Thea, Santen, Allergan, Alcon/Novartis. Dr Aspberg has received speaking honoraria from Allergan. Dr Andersson‐Geimer has nothing to disclose. Dr Lindén reports speaking honoraria from Allergan Nordic AB and Santen Pharma.

The trial is registered in EudraCT (Ref no. 2013‐002895‐42).
(Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Acta Ophthalmologica
volume
96
issue
(6)
pages
557 - 566
publisher
Wiley-Blackwell
external identifiers
  • scopus:85052842739
ISSN
1755-375X
DOI
10.1111/aos.13791
language
English
LU publication?
yes
id
0a2be708-6363-4915-bad5-249f2a39929e
date added to LUP
2018-09-01 19:11:02
date last changed
2019-01-06 14:03:13
@article{0a2be708-6363-4915-bad5-249f2a39929e,
  abstract     = {Crown Princess Margareta's Foundation, the Herman Järnhardt Foundation, the Foundation for Visually Impaired in Former Malmöhus County, Ögonfonden, Ingrid Nordmark's Foundation, the Margit and Kjell Stolz Foundation, foundations and donations administered by Skåne University Hospital, and King Gustav V and Queen Victoria's Freemason Foundation, Swedish Society for Medical Research, Swedish Medical Society Foundation and Cronqvist Foundation. Financial support was also provided through a regional agreement between Lund University and Skåne County Council (ALF) and by Umeå University and Västerbotten County Council (ALF).The sponsors and funding organizations had no role in the design or performance of this research.Acknowledgement/disclosures: The design of the GITS was briefly presented at the Nordic Glaucoma Congress in September 2017.The trial is supported by grants from Crown Princess Margareta's Foundation, the Herman Järnhardt Foundation, the Foundation for Visually Impaired in Former Malmöhus County, the Swedish Eye Foundation, Ingrid Nordmark's Foundation, the Margit and Kjell Stolz Foundation, foundations and donations administered by Skåne University Hospital, and King Gustav V and Queen Victoria's Freemason Foundation, Swedish Society for Medical Research, the Swedish Medical Society Foundation, and the Cronqvist Foundation. Financial support was also provided through a regional agreement between Lund University and Skåne County Council (ALF), and by Umeå University and Västerbotten County Council (ALF). The sponsors and funding organizations had no role in the design or performance of this research.Financial disclosures: Dr Bengtsson is a consultant to Carl Zeiss Meditec. Dr Heijl is a consultant to Carl Zeiss Meditec and Allergan, and has received speaking honoraria from Allergan, Zeiss and Santen. Dr Johannesson reports speaking honoraria and/or consulting for Topcon, Thea, Santen, Allergan, Alcon/Novartis. Dr Aspberg has received speaking honoraria from Allergan. Dr Andersson‐Geimer has nothing to disclose. Dr Lindén reports speaking honoraria from Allergan Nordic AB and Santen Pharma.<br/><br/>The trial is registered in EudraCT (Ref no. 2013‐002895‐42).<br/>},
  author       = {Bengtsson, Boel and Heijl, Anders and Johannesson, Gauti and Andersson-Geimer, Sabina and Aspberg, Johan and Lindén, Christina},
  issn         = {1755-375X},
  language     = {eng},
  month        = {08},
  number       = {(6)},
  pages        = {557--566},
  publisher    = {Wiley-Blackwell},
  series       = {Acta Ophthalmologica},
  title        = {The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data},
  url          = {http://dx.doi.org/10.1111/aos.13791},
  volume       = {96},
  year         = {2018},
}